CellaVision AB (publ) (CLVSF) Stock Forecast & Price Target

$20.24
0.00 (0.00%)
(As of 05/17/2024 ET)

CellaVision AB (publ) - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 1 Analyst Ratings

Consensus Price Target

N/A

TypeCurrent Forecast
5/21/23 to 5/20/24
1 Month Ago
4/21/23 to 4/20/24
3 Months Ago
2/20/23 to 2/20/24
1 Year Ago
5/21/22 to 5/21/23
Consensus Rating
Buy
Buy
Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Get CellaVision AB (publ) Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CLVSF and its competitors with MarketBeat's FREE daily newsletter.

CLVSF Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CLVSF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CellaVision AB (publ) Stock vs. The Competition

TypeCellaVision AB (publ)Medical CompaniesS&P 500
Consensus Rating Score
3.00
2.69
2.49
Consensus RatingBuyModerate BuyHold
Predicted Upside848.68% Upside7.91% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Recent Analyst Forecasts and Stock Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/2/2023Pareto Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 02:53 PM ET.

CLVSF Frequently Asked Questions

What is CellaVision AB (publ)'s purchase recommendation?

According to the research reports of 1 Wall Street equities research analysts, The consensus rating for CellaVision AB (publ) stock is Buy based on the current 1 buy rating for CLVSF. Learn more on CLVSF's analyst rating history.

Do Wall Street analysts like CellaVision AB (publ) more than its competitors?

Analysts like CellaVision AB (publ) more than other "medical" companies. The consensus rating for CellaVision AB (publ) is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CLVSF compares to other companies.


Stock Forecasts and Research Tools

This page (OTCMKTS:CLVSF) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners